Search results
However, antibiotic treatment increases the time for excretion of Salmonella, and can also cause the excretion of fluoroquinolone-resistant Campylobacter. Therefore, considering the benefits and risks of treatment, empirical antibiotic therapy is not recommended for most patients except immune-suppressed patients and those with severe infections.
- Antimicrobials for treating symptomatic non‐typhoidal Salmonella ...
Routine antibiotic use for this infection could result in...
- Antimicrobials for treating symptomatic non‐typhoidal Salmonella ...
11 maj 2023 · Current recommendations are that antibiotics should be reserved for patients with severe disease or patients who are at a high risk for invasive disease. Historically, recommended regimens for the...
1 gru 2019 · The objective was to determine if shorter intravenous (IV) antibiotic (<7 days) for nontyphoidal Salmonella bacteremia (NTS-B) is noninferior to longer (≥7 days) in terms of 30-day emergency department (ER) or rehospitalization in healthy children.
Routine antibiotic use for this infection could result in persistent colonization and the spread of resistant bacterial strains. Objectives. To assess the efficacy and safety of giving antibiotics to people with NTS diarrhoea. Search methods.
19 paź 2017 · In general, the largest treatment effect was seen in patients with salmonellosis, followed by campylobacteriosis, but antimicrobial treatment also was accompanied by an increase in prolonged Salmonella shedding and occasional shedding of quinolone-resistant Campylobacter.
10 sty 2024 · Salmonellae are motile gram-negative bacilli that infect or colonize a wide range of mammalian hosts. Salmonellae cause a number of clinical infections in humans; these include: Gastroenteritis. Enteric fever (systemic illness with fever and abdominal symptoms) Bacteremia and endovascular infection.
20 cze 2022 · The optimal duration of intravenous (IV) antibiotic therapy for children with nontyphoidal Salmonella bacteremia (NTSB) is unknown. The objective of the authors of this study is to evaluate differences in outcomes among children with NTSB who received a short (≤3 days; short-duration group [SDG]) versus long (>3 days; long-duration group [LDG ...
